 Allogene Therapeutics, Inc. NASDAQ:ALLO Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Christine Cassiano - CCO David Chang - President and CEO Rafael Amado - EVP, Research Development and CMO Eric Schmidt - CFO Conference Call Participants Andrea Tan - Goldman Sachs Michael Yee - Jefferies Tyler Van Buren - Cowen Asthika Goonewardene - Truist Raju Prasad - William Blair Reni Benjamin - JMP Securities Mark Breidenbach - Oppenheimer John Newman - Canaccord Genuity Michael Schmidt - Guggenheim Partners Luca Issi - RBC Capital Markets Jason Gerberry - Bank of America Kalpit Patel - B. Riley David Dai - SMBC Jack Allen - Baird Brian Cheng - JPMorgan Robert Burns - H.C. 